Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Lcb01-0371
1. 1219707-39-7
2. Lcb01-0371
3. Lcb-01-0371
4. Lcb-010371
5. 43ep6xv33e
6. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
7. (5r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one
8. (5r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
9. (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
10. 2-oxazolidinone, 3-(4-(5,6-dihydro-1-methyl-1,2,4-triazin-4(1h)-yl)-3-fluorophenyl)-5-(hydroxymethyl)-, (5r)-
11. Unii-43ep6xv33e
12. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
13. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)oxazolidin-2-one
14. Delpazolid [inn]
15. Delpazolid [who-dd]
16. Delpazolid (lcb01-0371)
17. Chembl1673408
18. Schembl11969210
19. Gtpl10999
20. Bcp25650
21. Ex-a1715
22. Db13077
23. Lcb-01,0371
24. Ac-33876
25. Hy-100180
26. Cs-0018175
27. Q27258646
| Molecular Weight | 308.31 g/mol |
|---|---|
| Molecular Formula | C14H17FN4O3 |
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 308.12846858 g/mol |
| Monoisotopic Mass | 308.12846858 g/mol |
| Topological Polar Surface Area | 68.6 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 450 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
ABOUT THIS PAGE
71
PharmaCompass offers a list of Delpazolid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Delpazolid manufacturer or Delpazolid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Delpazolid manufacturer or Delpazolid supplier.
PharmaCompass also assists you with knowing the Delpazolid API Price utilized in the formulation of products. Delpazolid API Price is not always fixed or binding as the Delpazolid Price is obtained through a variety of data sources. The Delpazolid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Delpazolid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Delpazolid, including repackagers and relabelers. The FDA regulates Delpazolid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Delpazolid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Delpazolid supplier is an individual or a company that provides Delpazolid active pharmaceutical ingredient (API) or Delpazolid finished formulations upon request. The Delpazolid suppliers may include Delpazolid API manufacturers, exporters, distributors and traders.
Delpazolid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Delpazolid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Delpazolid GMP manufacturer or Delpazolid GMP API supplier for your needs.
A Delpazolid CoA (Certificate of Analysis) is a formal document that attests to Delpazolid's compliance with Delpazolid specifications and serves as a tool for batch-level quality control.
Delpazolid CoA mostly includes findings from lab analyses of a specific batch. For each Delpazolid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Delpazolid may be tested according to a variety of international standards, such as European Pharmacopoeia (Delpazolid EP), Delpazolid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Delpazolid USP).
